Residual risk in cardiovascular and renal diseases and the potential role of aldosterone synthase inhibitors - Top-Institutions - MDSpire

Residual risk in cardiovascular and renal diseases and the potential role of aldosterone synthase inhibitors

  • By

  • Kausik Umanath

  • Jamie P. Dwyer

  • Robert J. Mentz

  • May 29, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, Ohio

    Key Differentiators

    • Cardiology
    • Hypertension

  • #2

    Vanderbilt University Medical Center
    Vanderbilt University Medical Center

    Nashville, Tennessee

    Key Differentiators

    • Cardiology
    • Hypertension

  • #3

    Jackson Heart Study
    Jackson Heart Study

    Jackson, Mississippi

    Key Differentiators

    • Cardiology
    • Epidemiology

  • #4

    Taiwan Primary Aldosteronism Investigation
    Taiwan Primary Aldosteronism Investigation

    Taipei, Taiwan

    Key Differentiators

    • Endocrinology
    • Cardiology

  • #5

    Hatter Cardiovascular Institute
    Hatter Cardiovascular Institute

    London, England

    Key Differentiators

    • Cardiology
    • Research

Original Source(s)

Residual risk in cardiovascular and renal diseases and the potential role of aldosterone synthase inhibitors

  • by Kausik Umanath, Jamie P. Dwyer, Robert J. Mentz

  • May 29, 2026

Related Content

The effectiveness and safety of oral Chinese patent medicines in treating myocardial infarction complicated with heart failure: a network meta-analysis of 12 interventions

Retatrutide Shows 28% Weight Loss in Phase 3 Trial

Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction.

Correction: Association between systemic immune-inflammation index(SII) and all-cause and cardiovascular mortality in heart failure patients: a single-center retrospective analysis